Horizon broadens gene editing capabilities: CRISPR license extension & grant-funded research – Cambridge Network
|
Horizon broadens gene editing capabilities: CRISPR license extension & grant-funded research
Cambridge Network With this license amendment, Horizon now adds the right to use CRISPR edited cell lines in GMP biomanufacturing. This extends Horizon's coverage for CRISPR to include virtually all non-therapeutic applications, strengthening its core capabilities and … |
